Results from a crossover trial confirm anecdotal reports that patients with homonymous hemianopia benefit from wearing peripheral prism glasses.
Author: The Medical News
Neuroptis Biotech reports positive results from ML7 preclinical trials for eye surface diseases
Neuroptis Biotech, the ophthalmology drug research and development specialist, announces positive results in preclinical trials of the eye-drop formulation of its ML7 product. ML7 is intended for use in the treatment of eye surface diseases, particular…
Peripheral prism glasses provide simple mobility rehabilitation intervention for hemianopia
More than a million Americans suffer from hemianopia, or blindness in one half of the visual field in both eyes as the result of strokes, tumors or trauma. People with hemianopia frequently bump into walls, trip over objects, or walk into people on the…
Generating an alternative to IVIG therapy: an interview with Professor Richard Pleass, LSTM
IVIG is a hugely successful biological with FDA approval for treating idiopathic thrombocytopenic purpura (ITP), Kawasaki disease, Guillain-Barré syndrome, Graves ophthalmopathy and numerous polyneuropathies.
Children’s Hospital Los Angeles opens new outpatient care center in Santa Monica
Children’s Hospital Los Angeles opened the doors of its new outpatient care center in Santa Monica today. The pediatric medical facility, Children’s Hospital Los Angeles – Santa Monica, will be staffed by 10 physicians who are Board-Certified in seven …
Study investigates association between preterm birth and later retinal detachment
Children born extremely prematurely have up to a 19 times greater risk of retinal detachment later in life than peers born at term, according to a Swedish study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology.
Parent’s use of digital photography shown as effective tool in diagnosis of retinoblastoma
Can parents use digital cameras and smart phones to potentially screen their children for the most common form of pediatric eye cancer? Baylor University and Harvard Medical School researchers believe so.
NTU establishes new $60 million research institute in Nanomedicine
Nanyang Technological University is giving the development of nanotechnology a big boost, by establishing a new $60 million research institute in Nanomedicine, which focuses on the medical application of nanotechnology. An emerging field in drugs, nano…
New Dementia Service Center established as pilot project
In Germany, approximately 1.3 million people currently suffer from dementia. About 250,000 incident cases are estimated per year. Dementia is the leading cause of dependency and disability among older persons.
NEI-funded study explores methods to improve diagnosis, treatment of common eye diseases
If you’ve ever been sleep-deprived, you’ve probably had a firsthand glimpse of the blood vessels in your eyes. But what you haven’t seen—and what many eye care professionals cannot see as well as they would like—are the vessels closest to the retina, the light-sensitive tissue at the back of the eye.
Just 13 days in space may cause changes in eye structure, gene expression
Just 13 days in space may be enough to cause profound changes in eye structure and gene expression, report researchers from Houston Methodist, NASA Johnson Space Center, and two other institutions in the October 2013 issue of Gravitational and Space Re…
InnoCore, Allergan expand collaboration to develop ophthalmology medicines
InnoCore Pharmaceuticals today announced that it has signed an exclusive License and Collaboration Agreement with Allergan, Inc., a multi-specialty health care company headquartered in Irvine, California.
Study finds no evidence that stem cell therapy improves vision for children with ONH
A study performed at Children’s Hospital Los Angeles found no evidence that stem cell therapy improves vision for children with optic nerve hypoplasia. Their results are reported in the Journal of the American Association for Pediatric Ophthalmology an…
Adalimumab may be viable treatment option for patients with refractory pediatric uveitis
A new study published in the current issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) suggests that the biologic agent adalimumab may be a viable treatment option for patients with steroid-resistant re…
UCLA receives $7M grant to investigate links between substance abuse and HIV among minority men
The National Institute on Drug Abuse has awarded UCLA a $7 million grant to investigate the links between substance abuse and HIV among Latino and African-American men who have sex with men.
Skin cancer drug shows periocular promise
Early research suggests that patients with periocular basal cell carcinoma may benefit from treatment with a drug targeting the Hedgehog signaling pathway.
Regeneron announces topline results from Phase 3 study of EYLEA Injection in patients with Macular Edema following BRVO
Regeneron Pharmaceuticals, Inc. today announced positive topline results for EYLEA® (aflibercept) Injection from the Phase 3 VIBRANT study in patients with Macular Edema following Branch Retinal Vein Occlusion (BRVO).
Key marker in blood and urine identifies genetic mutations in gene responsible for RP
Research led by physician-scientists at Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine has produced a breakthrough discovery in diagnosing retinitis pigmentosa, a blinding disease that affects about 1 in 4,000 people i…
Researchers make breakthrough discovery in diagnosing retinitis pigmentosa
Research led by physician-scientists at Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine has produced a breakthrough discovery in diagnosing retinitis pigmentosa, a blinding disease that affects about 1 in 4,000 people i…
Statins may increase risk of cataracts among individuals above 30 years old
According to the Centers for Disease Control and Prevention, cataracts are the number one cause of vision loss in the United States. Nearly 22 million Americans age 40 and over have cataracts, while more than half of individuals age 80 and over suffer …